The technical nature of simulation methods – A New Referral to the Enlarged Board of Appeal
In decision T0489/14, the EPO Boards of Appeal have made a new referral to the Enlarged Board of Appeal regarding the patentable nature of computer-implemented simulation methods. Under European practice, methods implemented on a computer are only considered patentable if the method can be understood to have a “technical effect”. In particular, methods that are...
The patentability of plants and animals obtained by essentially biological processes – conflict or conformity of Article 53 EPC and the implementing regulations
A new Referral to the Enlarged Board of Appeal (EBA) has been submitted by the President of the EPO concerning the patentability of plants and animals obtained exclusively by essentially biological processes, G3/19. This Referral follows Technical Board of Appeal decision T1063/18, a case concerning the patentability of plants obtained by an essentially biological process....
The UK Patent Box
Key features of the Patent Box The Patent Box is an IP-related tax relief scheme for innovative companies that make a profit from patented inventions and are subject to UK corporation tax. The Patent Box regime aims to encourage innovative companies to locate, commercialise and retain their research and development in the UK. Under the...
SPCs based on third party marketing authorisations – an undeserved advantage or a legitimate interpretation of the SPC Regulation?
As a result of a recent High Court decision in the UK (2019 EWHC 388), the following question is being referred to the CJEU: “Does the SPC Regulation preclude the grant of an SPC to the proprietor of a basic patent in respect of a product which is the subject of a marketing authorisation held...
No additional protection for new formulations of old active ingredients
In March 2017, the High Court in the UK requested a preliminary ruling from the CJEU on the interpretation of Article 3(d) of the SPC Regulation (EC/469/2009). In particular, the following question was referred:- “Is Article 3(d) of the SPC Regulation to be interpreted as permitting the grant of an SPC where the marketing authorisation...
Attendee: Naomi Stevens
2019 Hong Kong Biotech Roadshow Cambridge 27 June 2019
Attendee: Emily Scott
WTR Event: Brand Protection Online Europe TM Conference – 14 October 2019
Attendee: Barbara Rigby
BioWednesday Cambridge: Creating Value While Dealing with Uncertainty – Using the Gig Economy as Part of the Solution
Attendee: Susi Fish
Business case for Diversity at the joint AIPLA/CIPA Diversity in IP lunch, 3 June 2019
Attendee: Susi Fish
Connected bubbles,27 June, London
Attendee: Henry Schlaefli
SKYKICK – SIMON MALYNICZ QC ON THE CJEU TRADE MARK CASE, 16 May, London
Attendee: Michael C. Maier, LL.M.
INTA TM administrations and practitioners meeting
AIPPI World Congress, London, September 2019
Read about latest developments in the Trade Marks field, as well as what’s going on with the team here at Boult Wade Tennant
In this edition we caution brand owners about applications by Gleissner; look at a modern day David and Goliath story involving McDonald’s and Irish rival Supermac’s; cover recent changes to UK TM law to be aware of; Canada’s new trade mark law coming into force later this year; and the latest developments in the Cadbury V Nestlé chocolate wars.
In this edition we talk more about the opening of our new office in Madrid, preparing your trade mark filings in light of Brexit, learning from Puma’s leaping cat case about taking decisions on reputation earlier on, and the new opposition procedures in Argentina that came into force last month.
Guest posts from other sources. Clicking on the links will take you to an external site.